GlassScriptPhysician profile
Leta M Vega
NPI 1578523478
$1,143.10
in general payments reported to CMS, 2019-2025
21 companies · $220 in 2025
The $220 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $182 · 2022: $53.05 · 2023: $445 · 2024: $243 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $908.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $152.10 | 2023-2025 | Myosure Tissue Removal Device, Coolseal Generator, Aptima |
| Abbvie INC. | $146.70 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $134.33 | 2025 | Gemtesa, Myfembree |
| Astrazeneca Pharmaceuticals LP | $123.54 | 2023 | |
| Organon LLC | $109.03 | 2021-2024 | Nexplanon, Nuvaring |
| Exeltis, USA INC. | $78.49 | 2021-2025 | Slynd |
| Kyowa Kirin, INC. | $63.39 | 2024 | Nourianz |
| Becton, Dickinson and Company | $39.81 | 2023 | Bd Max System, Bd Max Instrument |
| Agile Therapeutics, INC. | $36.99 | 2023 | Twirla |
| Exact Sciences Corporation | $34.64 | 2023-2024 | Cologuard Collection Kit |
| Mylan Pharmaceuticals INC. | $30.61 | 2021 | |
| Avion Pharmaceuticals | $28.44 | 2021 | |
| Abbott Laboratories | $23.99 | 2021 | |
| Novo Nordisk INC | $23.88 | 2024 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $20.34 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $20.21 | 2024 | |
| Mayne Pharma Commercial LLC | $19.01 | 2024 | |
| Amgen INC. | $16.87 | 2021 | |
| Merck Sharp & Dohme LLC | $14.54 | 2021 | |
| Ibsa Pharma INC. | $13.44 | 2024 | Tirosint, Licart |
| Coopersurgical, INC. | $12.75 | 2023 | Summit Doppler |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leta Vega listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.